Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Zentalis Pharmaceuticals (ZNTL) SEC Filings & 10K Form

Zentalis Pharmaceuticals logo
$1.99 +0.12 (+6.42%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 -0.04 (-2.26%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Zentalis Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
07/16/2025
6:02 PM		BlackRock, Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
06/18/2025
3:14 PM		Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:15 PM		Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:17 PM		Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:19 PM		Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
5:02 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
5:01 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:30 PM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/28/2025
5:02 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2025
11:15 PM		Zentalis Pharmaceuticals (Filer)
Form EFFECT
03/17/2025
5:13 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
11:13 AM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
7:06 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
5:29 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:30 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:31 PM		Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:32 PM		Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:33 PM		Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:37 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:06 PM		MILLENNIUM MANAGEMENT LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/03/2025
6:12 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:13 PM		Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:14 PM		Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
11:44 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/31/2025
9:09 AM		VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/29/2025
8:18 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
9:08 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/08/2025
5:49 PM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/10/2024
11:42 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/06/2024
10:44 AM		FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/03/2024
6:02 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:02 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:44 PM		Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:45 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM		Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:06 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
1:47 PM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
11/04/2024
1:16 PM		VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
7:59 PM		HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
11:50 AM		STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
10/07/2024
10:37 AM		FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/04/2024
5:01 PM		Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:02 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ZNTL) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
One tiny company just cracked Google’s $19B problem
Google, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...
True Market Insiders | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...
Crypto 101 Media | Sponsoredtc pixel
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...
Paradigm Press | Sponsoredtc pixel
Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel